{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:37:35Z","timestamp":1789925855256,"version":"4.0.1"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/nrgastro.2016.179","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T05:07:21Z","timestamp":1479877641000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Gastrointestinal aspects of vasculitides"],"prefix":"10.1038","volume":"14","author":[{"given":"Medha","family":"Soowamber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam V.","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"BFnrgastro2016179_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65, 1\u201311 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0889-8553(05)70032-7","volume":"27","author":"M Bailey","year":"1998","unstructured":"Bailey, M., Chapin, W., Licht, H. & Reynolds, J. C. The effects of vasculitis on the gastrointestinal tract and liver. Gastroenterol. Clin. North Am. 27, 747\u2013782 (1998).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"BFnrgastro2016179_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"L Guillevin","year":"1996","unstructured":"Guillevin, L. et al. Prognostic factors in polyarteritis nodosa and Churg\u2013Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75, 17\u201328 (1996).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/BOR.0000000000000127","volume":"27","author":"JC Mason","year":"2015","unstructured":"Mason, J. C. Takayasu arteritis: surgical interventions. Curr. Opin. Rheumatol. 27, 45\u201352 (2015).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrgastro2016179_CR5","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.lpm.2015.01.015","volume":"44","author":"F Alibaz-Oner","year":"2015","unstructured":"Alibaz-Oner, F. & Direskeneli, H. Update on Takayasu's arteritis. Presse Med. 44, e259\u2013e265 (2015).","journal-title":"Presse Med."},{"key":"BFnrgastro2016179_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/1756-185X.12309","volume":"17","author":"C Terao","year":"2014","unstructured":"Terao, C., Yoshifuji, H. & Mimori, T. Recent advances in Takayasu arteritis. Int. J. Rheum. Dis. 17, 238\u2013247 (2014).","journal-title":"Int. J. Rheum. Dis."},{"key":"BFnrgastro2016179_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00005792-198503000-00002","volume":"64","author":"S Hall","year":"1985","unstructured":"Hall, S. et al. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 64, 89\u201399 (1985).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.mayocp.2013.04.025","volume":"88","author":"J Schmidt","year":"2013","unstructured":"Schmidt, J. et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin. Proc. 88, 822\u2013830 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrgastro2016179_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1054-8807(02)00186-2","volume":"12","author":"A Reddi","year":"2003","unstructured":"Reddi, A. & Chetty, R. Primary aorto-esophageal fistula due to Takayasu's aortitis. Cardiovasc. Pathol. 12, 112\u2013114 (2003).","journal-title":"Cardiovasc. Pathol."},{"key":"BFnrgastro2016179_CR10","first-page":"1076","volume":"57","author":"CD Cohen","year":"1980","unstructured":"Cohen, C. D., Kirsch, R. E., Saunders, S. J., Campbell, J. A. & Terblanche, J. Takayasu's syndrome \u2014 evidence for a liver lesion. S. Afr. Med. J. 57, 1076\u20131078 (1980).","journal-title":"S. Afr. Med. J."},{"key":"BFnrgastro2016179_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.semarthrit.2015.07.006","volume":"45","author":"A Sy","year":"2016","unstructured":"Sy, A. et al. Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin. Arthritis Rheum. 45, 475\u2013482 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrgastro2016179_CR12","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.39157","volume":"67","author":"C Terao","year":"2015","unstructured":"Terao, C. et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence ratio and genetic overlap. Arthritis Rheumatol. 67, 2226\u20132232 (2015)","journal-title":"Arthritis Rheumatol."},{"key":"BFnrgastro2016179_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.1780370420","volume":"37","author":"GS Hoffman","year":"1994","unstructured":"Hoffman, G. S. et al. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 37, 578\u2013582 (1994).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/BOR.0000000000000265","volume":"28","author":"MJ Koster","year":"2016","unstructured":"Koster, M. J., Matteson, E. L. & Warrington, K. J. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis. Curr. Opin. Rheumatol. 28, 211\u2013217 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrgastro2016179_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10067-009-1333-6","volume":"29","author":"R Goel","year":"2010","unstructured":"Goel, R., Danda, D., Mathew, J. & Edwin, N. Mycophenolate mofetil in Takayasu's arteritis. Clin. Rheumatol. 29, 329\u2013332 (2010).","journal-title":"Clin. Rheumatol."},{"key":"BFnrgastro2016179_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/rheumatology\/ket320","volume":"53","author":"G Keser","year":"2014","unstructured":"Keser, G., Direskeneli, H. & Aksu, K. Management of Takayasu arteritis: a systematic review. Rheumatology 53, 793\u2013801 (2014).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR17","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.114.014321","volume":"132","author":"A Mekinian","year":"2015","unstructured":"Mekinian, A. et al. Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients. Circulation 132, 1693\u20131700 (2015).","journal-title":"Circulation"},{"key":"BFnrgastro2016179_CR18","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00556439?term (2015)."},{"key":"BFnrgastro2016179_CR19","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay, M. A. et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 61, 1454\u20131461 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11926-014-0480-1","volume":"17","author":"MA Gonzalez-Gay","year":"2015","unstructured":"Gonzalez-Gay, M. A. & Pina, T. Giant cell arteritis and polymyalgia rheumatica: an update. Curr. Rheumatol. Rep. 17, 6 (2015).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrgastro2016179_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/MD.0b013e3181646118","volume":"87","author":"CJ Scola","year":"2008","unstructured":"Scola, C. J., Li, C. & Upchurch, K. S. Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore) 87, 45\u201351 (2008).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","volume":"122","author":"JM Evans","year":"1995","unstructured":"Evans, J. M., O'Fallon, W. M. & Hunder, G. G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann. Intern. Med. 122, 502\u2013507 (1995).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2016179_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.revmed.2015.12.015","volume":"37","author":"B Bienvenu","year":"2016","unstructured":"Bienvenu, B. et al. Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). Rev. Med. Interne 37, 154\u2013165 (2016).","journal-title":"Rev. Med. Interne"},{"key":"BFnrgastro2016179_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF02231530","volume":"12","author":"Y Ilan","year":"1993","unstructured":"Ilan, Y. & Ben-Chetrit, E. Liver involvement in giant cell arteritis. Clin. Rheumatol. 12, 219\u2013222 (1993).","journal-title":"Clin. Rheumatol."},{"key":"BFnrgastro2016179_CR25","doi-asserted-by":"publisher","unstructured":"Xu, J., Bjornsson, E. S. & Sundaram, V. Severe cholestatic hepatitis due to large vessel vasculitis: report of two cases. Gastroenterol. Rep. http:\/\/dx.doi.org\/10.1093\/gastro\/gov061 (2015).","DOI":"10.1093\/gastro\/gov061"},{"key":"BFnrgastro2016179_CR26","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1093\/rheumatology\/ker278","volume":"50","author":"S Lee","year":"2011","unstructured":"Lee, S., Childerhouse, A. & Moss, K. Gastrointestinal symptoms and granulomatous vasculitis involving the liver in giant cell arteritis: a case report and review of the literature. Rheumatology 50, 2316\u20132317 (2011).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR27","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1023\/A:1018892122026","volume":"43","author":"MA Heneghan","year":"1998","unstructured":"Heneghan, M. A., Feeley, K. M., DeFaoite, N., Little, M. P. & O'Gorman, T. A. Granulomatous liver disease and giant-cell arteritis. Dig. Dis. Sci. 43, 2164\u20132167 (1998).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2016179_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3899\/jrheum.140562","volume":"42","author":"S Furuta","year":"2015","unstructured":"Furuta, S., Cousins, C., Chaudhry, A. & Jayne, D. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J. Rheumatol. 42, 300\u2013308 (2015).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2016179_CR29","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"AD Mahr","year":"2007","unstructured":"Mahr, A. D. et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum. 56, 2789\u20132797 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR30","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","volume":"387","author":"PM Villiger","year":"2016","unstructured":"Villiger, P. M. et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387, 1921\u20131927 (2016).","journal-title":"Lancet"},{"key":"BFnrgastro2016179_CR31","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01791153?term (2016)."},{"issue":"Suppl. 10","key":"BFnrgastro2016179_CR32","first-page":"9L","volume":"67","author":"CA Langford","year":"2015","unstructured":"Langford, C. A. et al. A randomized double-blind trial of abatacept and glucocorticoids for the treatment of giant cell arteritis [abstract]. Arthritis Rheum. 67 (Suppl. 10), 9L (2015).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","volume":"15","author":"A De Virgilio","year":"2016","unstructured":"De Virgilio, A. et al. Polyarteritis nodosa: a contemporary overview. Autoimmun. Rev. 15, 564\u2013570 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFnrgastro2016179_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0002-9343(01)01131-7","volume":"112","author":"SM Levine","year":"2002","unstructured":"Levine, S. M., Hellmann, D. B. & Stone, J. H. Gastrointestinal involvement in polyarteritis nodosa: presentation and outcomes in 24 patients (1986\u20132000). Am. J. Med. 112, 386\u2013391 (2002).","journal-title":"Am. J. Med."},{"key":"BFnrgastro2016179_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"C Pagnoux","year":"2005","unstructured":"Pagnoux, C., Mahr, A., Cohen, P. & Guillevin, L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg\u2013Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84, 115\u2013128 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.crad.2015.11.004","volume":"71","author":"M Singhal","year":"2016","unstructured":"Singhal, M. et al. Role of multidetector abdominal CT in the evaluation of abnormalities in polyarteritis nodosa. Clin. Radiol. 71, 222\u2013227 (2016).","journal-title":"Clin. Radiol."},{"key":"BFnrgastro2016179_CR37","doi-asserted-by":"publisher","unstructured":"Li, S. J. et al. Clinical and morphologic spectrum of renal involvement in patients with HBV-associated cryoglobulinemia. Nephrology http:\/\/dx.doi.org\/10.1111\/nep.12795 (2016).","DOI":"10.1111\/nep.12795"},{"key":"BFnrgastro2016179_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","volume":"84","author":"L Guillevin","year":"2005","unstructured":"Guillevin, L. et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84, 313\u2013322 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.rdc.2014.09.005","volume":"41","author":"L Forbess","year":"2015","unstructured":"Forbess, L. & Bannykh, S. Polyarteritis nodosa. Rheum. Dis. Clin. North Am. 41, 33\u201346 (2015).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrgastro2016179_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr, A., Guillevin, L., Poissonnet, M. & Ayme, S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg\u2013Strauss syndrome in a French urban multiethnic population in 2000: a capture\u2013recapture estimate. Arthritis Rheum. 51, 92\u201399 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.md.0000180793.80212.17","volume":"84","author":"A Bourgarit","year":"2005","unstructured":"Bourgarit, A. et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 84, 323\u2013330 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR42","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.27240","volume":"62","author":"C Pagnoux","year":"2010","unstructured":"Pagnoux, C. et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 62, 616\u2013626 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/1756-185X.12223","volume":"17","author":"A Sharma","year":"2014","unstructured":"Sharma, A. et al. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int. J. Rheum. Dis. 17, 562\u2013572 (2014).","journal-title":"Int. J. Rheum. Dis."},{"key":"BFnrgastro2016179_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/art.10922","volume":"49","author":"L Guillevin","year":"2003","unstructured":"Guillevin, L. et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum. 49, 93\u2013100 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.autrev.2013.10.001","volume":"13","author":"M Samson","year":"2014","unstructured":"Samson, M. et al. Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors. Autoimmun. Rev. 13, 197\u2013205 (2014).","journal-title":"Autoimmun. Rev."},{"issue":"Suppl. 10","key":"BFnrgastro2016179_CR46","first-page":"1086","volume":"67","author":"X Puechal","year":"2015","unstructured":"Puechal, X. et al. Does adding azathioprine to glucocorticoid induction increase the remission rate and prevent relapses in patients with systemic necrotizing vasculitides without poor-prognosis factors? A multicenter, double-blind randomized controlled trial [abstract]. Arthritis Rheum. 67 (Suppl. 10), 1086 (2015).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/art.20401","volume":"51","author":"L Guillevin","year":"2004","unstructured":"Guillevin, L. et al. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum. 51, 482\u2013487 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR48","first-page":"S71","volume":"24","author":"C Pagnoux","year":"2006","unstructured":"Pagnoux, C., Cohen, P. & Guillevin, L. Vasculitides secondary to infections. Clin. Exp. Rheumatol. 24, S71\u2013S81 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrgastro2016179_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2188\/jea.JE20140089","volume":"25","author":"N Makino","year":"2015","unstructured":"Makino, N. et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J. Epidemiol. 25, 239\u2013245 (2015).","journal-title":"J. Epidemiol."},{"key":"BFnrgastro2016179_CR50","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/archdischild-2014-307536","volume":"100","author":"S Singh","year":"2015","unstructured":"Singh, S., Vignesh, P. & Burgner, D. The epidemiology of Kawasaki disease: a global update. Arch. Dis. Child. 100, 1084\u20131088 (2015).","journal-title":"Arch. Dis. Child."},{"key":"BFnrgastro2016179_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.autrev.2015.11.010","volume":"15","author":"JB Fraison","year":"2016","unstructured":"Fraison, J. B. et al. Kawasaki disease in adults: observations in France and literature review. Autoimmun. Rev. 15, 242\u2013249 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFnrgastro2016179_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/MD.0b013e3181df193c","volume":"89","author":"E Gomard-Mennesson","year":"2010","unstructured":"Gomard-Mennesson, E. et al. Kawasaki disease in adults: report of 10 cases. Medicine (Baltimore) 89, 149\u2013158 (2010).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR53","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jpeds.2008.10.006","volume":"154","author":"AL Baker","year":"2009","unstructured":"Baker, A. L. et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J. Pediatr. 154, 592\u2013595. e2 (2009).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2016179_CR54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1067\/mpd.2003.232","volume":"142","author":"F Zulian","year":"2003","unstructured":"Zulian, F. et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J. Pediatr. 142, 731\u2013735 (2003).","journal-title":"J. Pediatr."},{"key":"BFnrgastro2016179_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/pch\/12.3.235","volume":"12","author":"R Singh","year":"2007","unstructured":"Singh, R., Ward, C., Walton, M. & Persad, R. Atypical Kawasaki disease and gastrointestinal manifestations. Paediatr. Child Health 12, 235\u2013237 (2007).","journal-title":"Paediatr. Child Health"},{"key":"BFnrgastro2016179_CR56","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/jpc.12221","volume":"49","author":"D Yim","year":"2013","unstructured":"Yim, D., Curtis, N., Cheung, M. & Burgner, D. An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes. J. Paediatr. Child Health 49, 614\u2013623 (2013).","journal-title":"J. Paediatr. Child Health"},{"key":"BFnrgastro2016179_CR57","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger, J. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114, 1708\u20131733 (2004).","journal-title":"Pediatrics"},{"key":"BFnrgastro2016179_CR58","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","volume":"11","author":"ST Shulman","year":"2015","unstructured":"Shulman, S. T. & Rowley, A. H. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat. Rev. Rheumatol. 11, 475\u2013482 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrgastro2016179_CR59","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1148\/radiographics.20.3.g00mc02779","volume":"20","author":"HK Ha","year":"2000","unstructured":"Ha, H. K. et al. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics 20, 779\u2013794 (2000).","journal-title":"Radiographics"},{"key":"BFnrgastro2016179_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0889-857X(21)00479-8","volume":"21","author":"F Lhote","year":"1995","unstructured":"Lhote, F. & Guillevin, L. Polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome. Clinical aspects and treatment. Rheum. Dis. Clin. North Am. 21, 911\u2013947 (1995).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrgastro2016179_CR61","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1055\/s-0031-1279824","volume":"32","author":"A Gibelin","year":"2011","unstructured":"Gibelin, A., Maldini, C. & Mahr, A. Epidemiology and etiology of Wegener granulomatosis, microscopic polyangiitis, Churg\u2013Strauss syndrome and Goodpasture syndrome: vasculitides with frequent lung involvement. Semin. Respir. Crit. Care Med. 32, 264\u2013273 (2011).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"BFnrgastro2016179_CR62","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11605-011-1735-z","volume":"16","author":"S Akbulut","year":"2012","unstructured":"Akbulut, S. Multiple ileal perforations in a patient with Wegener's granulomatosis: a case report and literature review. J. Gastrointest. Surg. 16, 857\u2013862 (2012).","journal-title":"J. Gastrointest. Surg."},{"key":"BFnrgastro2016179_CR63","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s00261-014-0334-3","volume":"40","author":"J Nay","year":"2015","unstructured":"Nay, J., Menias, C. O., Mellnick, V. M. & Balfe, D. M. Gastrointestinal manifestations of systemic disease: a multimodality review. Abdom. Imaging. 40, 1926\u20131943 (2015).","journal-title":"Abdom. Imaging."},{"key":"BFnrgastro2016179_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.giec.2006.01.013","volume":"16","author":"A Schneider","year":"2006","unstructured":"Schneider, A., Merikhi, A. & Frank, B. B. Autoimmune disorders: gastrointestinal manifestations and endoscopic findings. Gastrointest. Endosc. Clin. N. Am. 16, 133\u2013151 (2006).","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"key":"BFnrgastro2016179_CR65","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/rheumatology\/kev199","volume":"54","author":"S Humbert","year":"2015","unstructured":"Humbert, S. et al. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group. Rheumatology 54, 1970\u20131975 (2015).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR66","first-page":"141","volume":"52","author":"M Camilleri","year":"1983","unstructured":"Camilleri, M., Pusey, C. D., Chadwick, V. S. & Rees, A. J. Gastrointestinal manifestations of systemic vasculitis. Q. J. Med. 52, 141\u2013149 (1983).","journal-title":"Q. J. Med."},{"key":"BFnrgastro2016179_CR67","first-page":"267","volume":"26","author":"Y Valerieva","year":"2013","unstructured":"Valerieva, Y., Golemanov, B., Tzolova, N. & Mitova, R. Pancreatic mass as an initial presentation of severe Wegener's granulomatosis. Ann. Gastroenterol. 26, 267\u2013269 (2013).","journal-title":"Ann. Gastroenterol."},{"key":"BFnrgastro2016179_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/rheumatology\/kev286","volume":"55","author":"JH Schirmer","year":"2016","unstructured":"Schirmer, J. H. et al. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology 55, 71\u201379 (2016).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","volume":"26","author":"M Groh","year":"2015","unstructured":"Groh, M. et al. Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur. J. Intern. Med. 26, 545\u2013553 (2015).","journal-title":"Eur. J. Intern. Med."},{"key":"BFnrgastro2016179_CR70","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond, C. et al. Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 65, 270\u2013281 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR71","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig, F. et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg\u2013Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis. 72, 1011\u20131017 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016179_CR72","first-page":"243","volume":"9","author":"C Pagnoux","year":"2010","unstructured":"Pagnoux, C. Churg\u2013Strauss syndrome: evolving concepts. Discov. Med. 9, 243\u2013252 (2010).","journal-title":"Discov. Med."},{"key":"BFnrgastro2016179_CR73","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","volume":"44","author":"M Gayraud","year":"2001","unstructured":"Gayraud, M. et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 44, 666\u2013675 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/art.27763","volume":"63","author":"JU Holle","year":"2011","unstructured":"Holle, J. U. et al. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum. 63, 257\u2013266 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR75","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann, O. et al. Long-term patient survival in ANCA-associated vasculitis. Ann. Rheum. Dis. 70, 488\u2013494 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016179_CR76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221\u2013232 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016179_CR77","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","volume":"125","author":"S Kim","year":"2010","unstructured":"Kim, S., Marigowda, G., Oren, E., Israel, E. & Wechsler, M. E. Mepolizumab as a steroid-sparing treatment option in patients with Churg\u2013Strauss syndrome. J. Allergy Clin. Immunol. 125, 1336\u20131343 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrgastro2016179_CR78","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02020889?term (2016)."},{"key":"BFnrgastro2016179_CR79","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","volume":"359","author":"C Pagnoux","year":"2008","unstructured":"Pagnoux, C. et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N. Engl. J. Med. 359, 2790\u20132803 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016179_CR80","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"TF Hiemstra","year":"2010","unstructured":"Hiemstra, T. F. et al. Mycophenolate mofetil versus azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 304, 2381\u20132388 (2010).","journal-title":"JAMA"},{"key":"BFnrgastro2016179_CR81","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin, L. et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N. Engl. J. Med. 371, 1771\u20131780 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016179_CR82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3899\/jrheum.150376","volume":"43","author":"L McGeoch","year":"2016","unstructured":"McGeoch, L. et al. CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides. J. Rheumatol. 43, 97\u2013120 (2016).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2016179_CR83","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","volume":"14","author":"A Audemard-Verger","year":"2015","unstructured":"Audemard-Verger, A., Pillebout, E., Guillevin, L., Thervet, E. & Terrier, B. IgA vasculitis (Henoch\u2013Sh\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun. Rev. 14, 579\u2013585 (2015).","journal-title":"Autoimmun. Rev."},{"key":"BFnrgastro2016179_CR84","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.revmed.2013.12.004","volume":"35","author":"E Pillebout","year":"2014","unstructured":"Pillebout, E. & Verine, J. [Henoch\u2013Sch\u00f6nlein purpura in the adult]. Rev. Med. Interne 35, 372\u2013381 (in French) (2014).","journal-title":"Rev. Med. Interne"},{"key":"BFnrgastro2016179_CR85","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10620-007-0147-0","volume":"53","author":"EC Ebert","year":"2008","unstructured":"Ebert, E. C. Gastrointestinal manifestations of Henoch\u2013Sch\u00f6nlein purpura. Dig. Dis. Sci. 53, 2011\u20132019 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2016179_CR86","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0016-5107(02)70376-3","volume":"56","author":"M Esaki","year":"2002","unstructured":"Esaki, M. et al. Gastrointestinal involvement in Henoch\u2013Sch\u00f6nlein purpura. Gastrointest. Endosc. 56, 920\u2013923 (2002).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2016179_CR87","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1055\/s-0034-1377757","volume":"46","author":"EJ Nam","year":"2014","unstructured":"Nam, E. J. et al. Gastrointestinal bleeding in adult patients with Henoch\u2013Sch\u00f6nlein purpura. Endoscopy 46, 981\u2013986 (2014).","journal-title":"Endoscopy"},{"key":"BFnrgastro2016179_CR88","first-page":"63","volume":"41","author":"HC Chao","year":"2000","unstructured":"Chao, H. C., Kong, M. S. & Lin, S. J. Hepatobiliary involvement of Henoch\u2013Sch\u00f6nlein purpura in children. Acta Paediatr. Taiwan 41, 63\u201368 (2000).","journal-title":"Acta Paediatr. Taiwan"},{"key":"BFnrgastro2016179_CR89","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ki.2010.150","volume":"78","author":"E Pillebout","year":"2010","unstructured":"Pillebout, E. et al. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Sch\u00f6nlein purpura. Kidney Int. 78, 495\u2013502 (2010).","journal-title":"Kidney Int."},{"key":"BFnrgastro2016179_CR90","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/ndt\/gfr137","volume":"26","author":"E Pillebout","year":"2011","unstructured":"Pillebout, E. et al. Successful outcome using rituximab as the only immunomodulation in Henoch\u2013Sch\u00f6nlein purpura: case report. Nephrol. Dial. Transplant. 26, 2044\u20132046 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrgastro2016179_CR91","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0009922814568288","volume":"54","author":"T Chou","year":"2015","unstructured":"Chou, T. et al. Successful treatment of Henoch\u2013Sch\u00f6nlein purpura with recurrent gastrointestinal involvement with mycophenolate mofetil: a brief report. Clin. Pediatr. 54, 900\u2013903 (2015).","journal-title":"Clin. Pediatr."},{"key":"BFnrgastro2016179_CR92","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","volume":"33","author":"C Ferri","year":"2004","unstructured":"Ferri, C. et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin. Arthritis Rheum. 33, 355\u2013374 (2004).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrgastro2016179_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.rdc.2014.09.008","volume":"41","author":"D Ghetie","year":"2015","unstructured":"Ghetie, D., Mehraban, N. & Sibley, C. H. Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances. Rheum. Dis. Clin. North Am. 41, 93\u2013108 (2015).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrgastro2016179_CR94","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10238-016-0410-9","volume":"16","author":"F Dammacco","year":"2016","unstructured":"Dammacco, F., Racanelli, V., Russi, S. & Sansonno, D. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clin. Exp. Med. 16, 233\u2013242 (2016).","journal-title":"Clin. Exp. Med."},{"key":"BFnrgastro2016179_CR95","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/annrheumdis-2013-203883","volume":"73","author":"P Cacoub","year":"2014","unstructured":"Cacoub, P., Terrier, B. & Saadoun, D. Hepatitis C virus-induced vasculitis: therapeutic options. Ann. Rheum. Dis. 73, 24\u201330 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016179_CR96","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","volume":"128","author":"P Cacoub","year":"2015","unstructured":"Cacoub, P., Comarmond, C., Domont, F., Savey, L. & Saadoun, D. Cryoglobulinemia vasculitis. Am. J. Med. 128, 950\u2013955 (2015).","journal-title":"Am. J. Med."},{"key":"BFnrgastro2016179_CR97","doi-asserted-by":"publisher","unstructured":"Retamozo, S. et al. Life-threatening cryoglobulinemic patients with hepatitis C: clinical description and outcome of 279 patients. Medicine (Baltimore) http:\/\/dx.doi.org\/10.1097\/MD.0b013e3182a5cf71 (2013).","DOI":"10.1097\/MD.0b013e3182a5cf71"},{"key":"BFnrgastro2016179_CR98","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/art.30319","volume":"63","author":"B Terrier","year":"2011","unstructured":"Terrier, B. et al. Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum. 63, 1748\u20131757 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR99","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/annrheumdis-2012-201405","volume":"72","author":"B Terrier","year":"2013","unstructured":"Terrier, B. et al. Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. Ann. Rheum. Dis. 72, 374\u2013380 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016179_CR100","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"Sise, M. E. et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology 63, 408\u2013417 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016179_CR101","first-page":"84","volume":"28","author":"L Quartuccio","year":"2010","unstructured":"Quartuccio, L. et al. Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia. Clin. Exp. Rheumatol. 28, 84\u201387 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrgastro2016179_CR102","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/annrheumdis-2012-202770","volume":"73","author":"D Saadoun","year":"2014","unstructured":"Saadoun, D. et al. Peg-IFN\u03b1\/ribavirin\/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann. Rheum. Dis. 73, 831\u2013837 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016179_CR103","first-page":"1404","volume":"26","author":"AC Ho","year":"1999","unstructured":"Ho, A. C., Roat, M. I., Venbrux, A. & Hellmann, D. B. Cogan's syndrome with refractory abdominal aortitis and mesenteric vasculitis. J. Rheumatol. 26, 1404\u20131407 (1999).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2016179_CR104","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.revmed.2013.12.005","volume":"35","author":"A Mahr","year":"2014","unstructured":"Mahr, A. & Maldini, C. [Epidemiology of Beh\u00e7et's disease]. Rev. Med. Interne 35, 81\u201389 (in French) (2014).","journal-title":"Rev. Med. Interne"},{"key":"BFnrgastro2016179_CR105","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3748\/wjg.v21.i13.3801","volume":"21","author":"W Skef","year":"2015","unstructured":"Skef, W., Hamilton, M. J. & Arayssi, T. Gastrointestinal Beh\u00e7et's disease: a review. World J. Gastroenterol. 21, 3801\u20133812 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016179_CR106","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3899\/jrheum.131227","volume":"41","author":"C Sibley","year":"2014","unstructured":"Sibley, C. et al. Beh\u00e7et syndrome manifestations and activity in the United States versus Turkey \u2014 a cross-sectional cohort comparison. J. Rheumatol. 41, 1379\u20131384 (2014).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2016179_CR107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0028-1103481","volume":"41","author":"SK Lee","year":"2009","unstructured":"Lee, S. K., Kim, B. K., Kim, T. I. & Kim, W. H. Differential diagnosis of intestinal Beh\u00e7et's disease and Crohn's disease by colonoscopic findings. Endoscopy 41, 9\u201316 (2009).","journal-title":"Endoscopy"},{"key":"BFnrgastro2016179_CR108","first-page":"S140","volume":"32","author":"AG Vaiopoulos","year":"2014","unstructured":"Vaiopoulos, A. G., Sfikakis, P. P., Kanakis, M. A., Vaiopoulos, G. & Kaklamanis, P. G. Gastrointestinal manifestations of Beh\u00e7et's disease: advances in evaluation and management. Clin. Exp. Rheumatol. 32, S140\u2013S148 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrgastro2016179_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","volume":"7","author":"MJ Zeidan","year":"2016","unstructured":"Zeidan, M. J. et al. Beh\u00e7et's disease physiopathology: a contemporary review. Auto Immun. Highlights 7, 4 (2016).","journal-title":"Auto Immun. Highlights"},{"key":"BFnrgastro2016179_CR110","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/BF02361251","volume":"29","author":"H Orikasa","year":"1994","unstructured":"Orikasa, H. et al. A case of Beh\u00e7et's disease with occlusion of both caval veins and \u201cdownhill\u201d esophageal varices. J. Gastroenterol. 29, 506\u2013510 (1994).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016179_CR111","first-page":"727","volume":"85","author":"A Ozenc","year":"1990","unstructured":"Ozenc, A., Bayraktar, Y. & Baykal, A. Pyloric stenosis with esophageal involvement in Beh\u00e7et's syndrome. Am. J. Gastroenterol. 85, 727\u2013728 (1990).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016179_CR112","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1007\/s10620-009-1095-7","volume":"55","author":"CM Moon","year":"2010","unstructured":"Moon, C. M. et al. Prediction of free bowel perforation in patients with intestinal Beh\u00e7et's disease using clinical and colonoscopic findings. Dig. Dis. Sci. 55, 2904\u20132911 (2010).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2016179_CR113","first-page":"858","volume":"92","author":"Y Bayraktar","year":"1997","unstructured":"Bayraktar, Y., Balkanci, F., Bayraktar, M. & Calguneri, M. Budd\u2013Chiari syndrome: a common complication of Beh\u00e7et's disease. Am. J. Gastroenterol. 92, 858\u2013862 (1997).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016179_CR114","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.cgh.2014.08.042","volume":"13","author":"S Tanida","year":"2015","unstructured":"Tanida, S. et al. Adalimumab for the treatment of Japanese patients with intestinal Beh\u00e7et's disease. Clin. Gastroenterol. Hepatol. 13, 940\u2013948. e3 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016179_CR115","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi, G. et al. EULAR recommendations for the management of Beh\u00e7et disease. Ann. Rheum. Dis. 67, 1656\u20131662 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016179_CR116","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00296-004-0495-4","volume":"25","author":"SW Han","year":"2005","unstructured":"Han, S. W., Kim, G. W., Lee, J., Kim, Y. J. & Kang, Y. M. Successful treatment with stent angioplasty for Budd\u2013Chiari syndrome in Beh\u00e7et's disease. Rheumatol. Int. 25, 234\u2013237 (2005).","journal-title":"Rheumatol. Int."},{"key":"BFnrgastro2016179_CR117","first-page":"2848","volume":"95","author":"M Naganuma","year":"2000","unstructured":"Naganuma, M. et al. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Beh\u00e7et's disease. Am. J. Gastroenterol. 95, 2848\u20132851 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016179_CR118","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1177\/0961203316642308","volume":"25","author":"M Fawzy","year":"2016","unstructured":"Fawzy, M., Edrees, A., Okasha, H., El Ashmaui, A. & Ragab, G. Gastrointestinal manifestations in systemic lupus erythematosus. Lupus 25, 1456\u20131462 (2016).","journal-title":"Lupus"},{"key":"BFnrgastro2016179_CR119","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11926-014-0440-9","volume":"16","author":"L Barile-Fabris","year":"2014","unstructured":"Barile-Fabris, L., Hernandez-Cabrera, M. F. & Barragan-Garfias, J. A. Vasculitis in systemic lupus erythematosus. Curr. Rheumatol. Rep. 16, 440 (2014).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrgastro2016179_CR120","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrrheum.2009.53","volume":"5","author":"JH Ju","year":"2009","unstructured":"Ju, J. H. et al. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat. Rev. Rheumatol. 5, 273\u2013281 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrgastro2016179_CR121","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1750-1172-8-67","volume":"8","author":"P Janssens","year":"2013","unstructured":"Janssens, P. et al. Lupus enteritis: from clinical findings to therapeutic management. Orphanet J. Rare Dis. 8, 67 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrgastro2016179_CR122","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.semarthrit.2013.11.005","volume":"43","author":"S Yuan","year":"2014","unstructured":"Yuan, S. et al. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease. Semin. Arthritis Rheum. 43, 759\u2013766 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrgastro2016179_CR123","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.berh.2005.04.002","volume":"19","author":"CC Mok","year":"2005","unstructured":"Mok, C. C. Investigations and management of gastrointestinal and hepatic manifestations of systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 19, 741\u2013766 (2005).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"BFnrgastro2016179_CR124","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/0046-8177(92)90033-Y","volume":"23","author":"T Matsumoto","year":"1992","unstructured":"Matsumoto, T. et al. The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese autopsy registry data. Hum. Pathol. 23, 1151\u20131158 (1992).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro2016179_CR125","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/rheumatology\/ket475","volume":"53","author":"A Makol","year":"2014","unstructured":"Makol, A. et al. Vasculitis associated with rheumatoid arthritis: a case\u2013control study. Rheumatology 53, 890\u2013899 (2014).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR126","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/art.24775","volume":"60","author":"C Bartels","year":"2009","unstructured":"Bartels, C., Bell, C., Rosenthal, A., Shinki, K. & Bridges, A. Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study. Arthritis Rheum. 60, 2553\u20132557 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016179_CR127","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10620-010-1508-7","volume":"56","author":"EC Ebert","year":"2011","unstructured":"Ebert, E. C. & Hagspiel, K. D. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Dig. Dis. Sci. 56, 295\u2013302 (2011).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2016179_CR128","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MD.0000000000000205","volume":"93","author":"J Hernandez-Rodriguez","year":"2014","unstructured":"Hernandez-Rodriguez, J., Tan, C. D., Rodriguez, E. R. & Hoffman, G. S. Single-organ gallbladder vasculitis: characterization and distinction from systemic vasculitis involving the gallbladder. An analysis of 61 patients. Medicine (Baltimore) 93, 405\u2013413 (2014).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016179_CR129","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/rheumatology\/keq093","volume":"49","author":"C Salvarani","year":"2010","unstructured":"Salvarani, C. et al. Localized vasculitis of the gastrointestinal tract: a case series. Rheumatology 49, 1326\u20131335 (2010).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR130","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/BOR.0b013e32834d8482","volume":"24","author":"J Hernandez-Rodriguez","year":"2012","unstructured":"Hernandez-Rodriguez, J. & Hoffman, G. S. Updating single-organ vasculitis. Curr. Opin. Rheumatol. 24, 38\u201345 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrgastro2016179_CR131","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.rdc.2014.09.011","volume":"41","author":"EM Miloslavsky","year":"2015","unstructured":"Miloslavsky, E. M., Stone, J. H. & Unizony, S. H. Challenging mimickers of primary systemic vasculitis. Rheum. Dis. Clin. North Am. 41, 141\u2013160 (2015).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrgastro2016179_CR132","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/jgh.13390","volume":"31","author":"FJ Senatore","year":"2016","unstructured":"Senatore, F. J. & McDonald, K. Gastrointestinal: ischemic gastrointestinal manifestations in a young adult: implicating a rare initial presentation of antiphospholipid syndrome. J. Gastroenterol. Hepatol. 31, 1381 (2016).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016179_CR133","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan, P. et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N. Engl. J. Med. 370, 921\u2013931 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016179_CR134","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa, T., Zen, Y., Pillai, S. & Stone, J. H. IgG4-related disease. Lancet 385, 1460\u20131471 (2015).","journal-title":"Lancet"},{"key":"BFnrgastro2016179_CR135","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1056\/NEJM200009213431207","volume":"343","author":"JW Olin","year":"2000","unstructured":"Olin, J. W. Thromboangiitis obliterans (Buerger's disease). N. Engl. J. Med. 343, 864\u2013869 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016179_CR136","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.bor.0000198000.58073.aa","volume":"18","author":"JW Olin","year":"2006","unstructured":"Olin, J. W. & Shih, A. Thromboangiitis obliterans (Buerger's disease). Curr. Opin. Rheumatol. 18, 18\u201324 (2006).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrgastro2016179_CR137","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/rheumatology\/kel388","volume":"46","author":"X Puechal","year":"2007","unstructured":"Puechal, X. & Fiessinger, J. N. Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist. Rheumatology 46, 192\u2013199 (2007).","journal-title":"Rheumatology"},{"key":"BFnrgastro2016179_CR138","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5009\/gnl.2010.4.2.287","volume":"4","author":"KS Lee","year":"2010","unstructured":"Lee, K. S. et al. Colon ischemia associated with Buerger's disease: case report and review of the literature. Gut Liver 4, 287\u2013291 (2010).","journal-title":"Gut Liver"},{"key":"BFnrgastro2016179_CR139","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00004836-200101000-00020","volume":"32","author":"Z Hassoun","year":"2001","unstructured":"Hassoun, Z., Lacrosse, M. & De Ronde, T. Intestinal involvement in Buerger's disease. J. Clin. Gastroenterol. 32, 85\u201389 (2001).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2016179_CR140","first-page":"CD011033","volume":"3","author":"DG Cacione","year":"2016","unstructured":"Cacione, D. G., Macedo, C. R. & Baptista-Silva, J. C. Pharmacological treatment for Buerger's disease. Cochrane Database Syst. Rev. 3, CD011033 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrgastro2016179_CR141","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1016\/j.jacc.2004.09.029","volume":"44","author":"LT Cooper","year":"2004","unstructured":"Cooper, L. T. et al. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J. Am. Coll. Cardiol. 44, 2410\u20132411 (2004).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.179","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T19:19:42Z","timestamp":1718911182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":141,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFnrgastro2016179"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.179","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]},"assertion":[{"value":"23 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.P. reports receiving fees for serving on advisory boards from Chemocentryx, GlaxoSmithKline and Hoffman-LaRoche; he also reports lecture fees and grant support from Bristol-Myers Squibb, EuroImmune, Hoffman-LaRoche and Terumo-BCT.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}